Evidence map›Paper›PMID 41458780›Full record

ArticleCureus2025

Hyperkeratosis Lenticularis Perstans (Flegel's Disease) in a Middle-Aged Man: A Rare Keratinization Disorder.

Khuzama M Alaseeri, Renad S Alshaikh, Deemah H Attar, Abdulrahman A Alharbi, Khalid Al Hawsawi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khuzama M AlaseeriCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Renad S AlshaikhCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Deemah H AttarCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Abdulrahman A AlharbiDepartment of Medicine, Ministry of National Guard Health Affairs, Jeddah, SAU.
Khalid Al HawsawiDepartment of Dermatology, Ministry of National Guard Health Affairs, Jeddah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flegel disease, also known as hyperkeratosis lenticularis perstans, is a rare cutaneous disease. Here, we report a case of a 56-year-old man who presented with a history of asymptomatic skin lesions that had gradually increased in number over the past year, in the absence of any significant medical history or known predisposing factors for Flegel disease. Skin examination revealed multiple punctate, scaly, blanchable, erythematous papules measuring 1-2 mm in diameter and distributed symmetrically on both lower extremities. Scales were adherent to the peripheral edges of the papules. Palms, soles, scalp, and mucous membranes were not involved, and there was no family history of similar lesions. Punch biopsy revealed epidermal atrophy with an overlying zone of ortho-hyperkeratosis, contrasting with the normal keratin layer. The papillary dermis showed a lichenoid infiltrate and dilated blood vessels. These clinico-pathological findings correlated well with the clinical appearance of multiple scaly erythematous papules and confirmed the diagnosis of Flegel disease. Topical therapy with 0.1% betamethasone valerate ointment was started twice daily. The patient showed mild improvement with reduced scaling and erythema, and no adverse effects were observed. Regular periodic follow-up was scheduled, but the patient was lost to follow-up.

Indexed as

flegel diseasehlphyperkeratosis lenticularis perstanskeratinization disorderskin disease

Identifiers

PMID41458780
PMCPMC12743624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.